Merck stock steadies as Keytruda drives growth and investors weigh pipeline momentum

Merck stock steadies as Keytruda drives growth and investors weigh pipeline momentum  Ad-hoc-news.de

Summary aggregated from Ad-hoc-news.de's public RSS feed. The full reporting belongs to Ad-hoc-news.de — please read it on their site.